The present disclosure discloses a compound for activating AMPK, which is adenine and/or the pharmaceutically acceptable salts thereof. The present disclosure also discloses the use of the compound. The compound is useful to activate AMP-activated protein kinase (AMPK) and the compound is used in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.